Alpha-1 Antitrypsin Deficiency Canada Inc.
Registration:
1
of
1
(2022-03-09
to
2022-05-02)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Improve augmentation therapy options in the province of British Columbia through the establishment of a therapy category on the Canadian Blood Services Plasma Protein and Related Products Formulary to ensure all blood and blood products are equally accessible to Canadian patients who require them.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health
|